120 related articles for article (PubMed ID: 19996864)
1. The perinatal implications of angiogenic factors.
Smith GC; Wear H
Curr Opin Obstet Gynecol; 2009 Apr; 21(2):111-6. PubMed ID: 19996864
[TBL] [Abstract][Full Text] [Related]
2. Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: a possible therapeutic approach to preeclampsia.
Zhao Y; Zheng YF; Luo QQ; Yan T; Liu XX; Han L; Zou L
Placenta; 2014 Jul; 35(7):476-82. PubMed ID: 24840734
[TBL] [Abstract][Full Text] [Related]
3. Contrasting effects of chronic hypoxia and nitric oxide synthase inhibition on circulating angiogenic factors in a rat model of growth restriction.
Bahtiyar MO; Buhimschi C; Ravishankar V; Copel J; Norwitz E; Julien S; Guller S; Buhimschi IA
Am J Obstet Gynecol; 2007 Jan; 196(1):72.e1-6. PubMed ID: 17240241
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast.
Munaut C; Lorquet S; Pequeux C; Blacher S; Berndt S; Frankenne F; Foidart JM
Hum Reprod; 2008 Jun; 23(6):1407-15. PubMed ID: 18413304
[TBL] [Abstract][Full Text] [Related]
5. Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth.
Smith GC; Crossley JA; Aitken DA; Jenkins N; Lyall F; Cameron AD; Connor JM; Dobbie R
Obstet Gynecol; 2007 Jun; 109(6):1316-24. PubMed ID: 17540803
[TBL] [Abstract][Full Text] [Related]
6. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
[TBL] [Abstract][Full Text] [Related]
7. Circulating angiogenic factors and the risk of preeclampsia.
Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
[TBL] [Abstract][Full Text] [Related]
8. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia.
Nagamatsu T; Fujii T; Kusumi M; Zou L; Yamashita T; Osuga Y; Momoeda M; Kozuma S; Taketani Y
Endocrinology; 2004 Nov; 145(11):4838-45. PubMed ID: 15284201
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end products as an upstream molecule triggers ROS-induced sFlt-1 production in extravillous trophoblasts: a novel bridge between oxidative stress and preeclampsia.
Huang QT; Zhang M; Zhong M; Yu YH; Liang WZ; Hang LL; Gao YF; Huang LP; Wang ZJ
Placenta; 2013 Dec; 34(12):1177-82. PubMed ID: 24144948
[TBL] [Abstract][Full Text] [Related]
10. Advanced oxidation protein products enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts: a possible link between oxidative stress and preeclampsia.
Huang QT; Wang SS; Zhang M; Huang LP; Tian JW; Yu YH; Wang ZJ; Zhong M
Placenta; 2013 Oct; 34(10):949-52. PubMed ID: 23899470
[TBL] [Abstract][Full Text] [Related]
11. Angiogenic balance (sFlt-1/PlGF) and preeclampsia.
Lecarpentier E; Tsatsaris V
Ann Endocrinol (Paris); 2016 Jun; 77(2):97-100. PubMed ID: 27130072
[TBL] [Abstract][Full Text] [Related]
12. Altered methylation and expression patterns of genes regulating placental angiogenesis in preterm pregnancy.
Sundrani DP; Reddy US; Chavan-Gautam PM; Mehendale SS; Chandak GR; Joshi SR
Reprod Sci; 2014 Dec; 21(12):1508-17. PubMed ID: 24803508
[TBL] [Abstract][Full Text] [Related]
13. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.
Shibata E; Rajakumar A; Powers RW; Larkin RW; Gilmour C; Bodnar LM; Crombleholme WR; Ness RB; Roberts JM; Hubel CA
J Clin Endocrinol Metab; 2005 Aug; 90(8):4895-903. PubMed ID: 15886253
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide generation affects pro- and anti-angiogenic growth factor expression in primary human trophoblast.
Groesch KA; Torry RJ; Wilber AC; Abrams R; Bieniarz A; Guilbert LJ; Torry DS
Placenta; 2011 Dec; 32(12):926-31. PubMed ID: 21963217
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia--a step forward but not the definitive answer.
Foidart JM; Schaaps JP; Chantraine F; Munaut C; Lorquet S
J Reprod Immunol; 2009 Nov; 82(2):106-11. PubMed ID: 19853925
[TBL] [Abstract][Full Text] [Related]
16. Maternal and foetal angiogenic imbalance in congenital heart defects.
Llurba E; Sánchez O; Ferrer Q; Nicolaides KH; Ruíz A; Domínguez C; Sánchez-de-Toledo J; García-García B; Soro G; Arévalo S; Goya M; Suy A; Pérez-Hoyos S; Alijotas-Reig J; Carreras E; Cabero L
Eur Heart J; 2014 Mar; 35(11):701-7. PubMed ID: 24159191
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in understanding of preeclampsia.
Bdolah Y; Karumanchi SA; Sachs BP
Croat Med J; 2005 Oct; 46(5):728-36. PubMed ID: 16158464
[TBL] [Abstract][Full Text] [Related]
18. Circulating angiogenic factors and placental abruption.
Signore C; Mills JL; Qian C; Yu K; Lam C; Epstein FH; Karumanchi SA; Levine RJ
Obstet Gynecol; 2006 Aug; 108(2):338-44. PubMed ID: 16880304
[TBL] [Abstract][Full Text] [Related]
19. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
Lim JH; Kim SY; Park SY; Yang JH; Kim MY; Ryu HM
Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525
[TBL] [Abstract][Full Text] [Related]
20. Excess soluble fms-like tyrosine kinase 1 and low platelet counts in premature neonates of preeclamptic mothers.
Tsao PN; Wei SC; Su YN; Chou HC; Chen CY; Hsieh WS
Pediatrics; 2005 Aug; 116(2):468-72. PubMed ID: 16061605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]